SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034925
Filing Date
2024-11-13
Accepted
2024-11-13 16:22:45
Documents
67
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20240930_10q.htm   iXBRL 10-Q 855864
2 EXHIBIT 3.1 ex_743381.htm EX-3.1 2295
3 EXHIBIT 31.1 ex_743362.htm EX-31.1 12620
4 EXHIBIT 31.2 ex_743363.htm EX-31.2 12693
5 EXHIBIT 32.1 ex_743364.htm EX-32.1 4550
6 EXHIBIT 32.2 ex_743365.htm EX-32.2 4884
12 image1.jpg GRAPHIC 59420
13 image01.jpg GRAPHIC 160661
14 image2.jpg GRAPHIC 188021
15 image3.jpg GRAPHIC 65377
  Complete submission text file 0001437749-24-034925.txt   5006002

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA dmac-20240930.xsd EX-101.SCH 40332
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20240930_def.xml EX-101.DEF 270986
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20240930_lab.xml EX-101.LAB 228098
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20240930_pre.xml EX-101.PRE 296614
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20240930_cal.xml EX-101.CAL 32065
70 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20240930_10q_htm.xml XML 612503
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 241454666
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)